跳至主要内容
临床试验/NCT00208403
NCT00208403终止4 期

Randomised, Prospective, RSA, PMS Study Comparing Acryloc™ & Palacos R in Primary Total Hip Arthroplasty

DePuy International1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2002年10月1日最近更新:
适应症

试验速览

阶段
4 期
状态
终止
发起方
入组人数
36
试验地点
1
主要终点
Distal migration of the femoral prosthesis from the time of implantation to the 2 year follow-up assessment

研究概览

简要总结

The purpose of this study is to monitor the stability of a total hip replacement within the thigh bone when used in artificial hip joints implanted with two different bone cements, Acryloc™ and Palacos® R, in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be randomly allocated to Acryloc™ or Palacos® R and will be evaluated at regular intervals following hip surgery using patient, clinical, x-ray assessments and special x-rays which allow the stability of the hip implant to be determined

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
60 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • i) Male or female subjects, aged 60 to 75 years (inclusive), and with a weight of less than 100kg.
  • ii) Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.
  • iii) Subjects who, in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.
  • iv) Subjects with non-inflammatory arthritis of the hip.
  • v) Subjects who require a primary total hip arthroplasty and are treated at the arthroplasty section of the orthopaedics department at the Investigational Centre.
  • vi) Subjects who are considered suitable for a cemented femoral stem and cemented acetabular component.

排除标准

  • i) Subjects who, in the opinion of the Investigator, have an existing condition such as malignancy, severe osteoporosis, disabling musculo-skeletal problems (other than in the hips) or any other condition that would compromise their participation and follow-up in this study.
  • ii) Women who are pregnant.
  • iii) Subjects who are known drug or alcohol abusers or with psychological disorders that could effect follow-up care or treatment outcomes.
  • iv) Subjects who have participated in a clinical study with an investigational product in the last 6 month(s).
  • v) Subjects who are currently involved in any injury litigation claims.
  • vi) Subjects undergoing corticosteroid treatment.
  • vii) Subjects with any condition for whom the use of conventional bone cement is contra-indicated.

结局指标

主要结局

Distal migration of the femoral prosthesis from the time of implantation to the 2 year follow-up assessment

时间窗: 2 Year

次要结局

  • Radiographic analysis(Annually)
  • Kaplan-Meier Survivorship - Revision of any component for any reason(Throughout Study)
  • Annual posterior (AP) and medio-lateral (ML) RSA translations(Annually)
  • Merle D'Aubigne score(Annually)

研究者

发起方
DePuy International
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验